Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2159-2164, June 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanigawa, N.
Right arrow Articles by Morton, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanigawa, N.
Right arrow Articles by Morton, D. L.

Rapid Assay for Evaluating the Chemosensitivity of Human Tumors in Soft Agar Culture1

Nobuhiko Tanigawa2, David H. Kern, Yorinori Hikasa and Donaid L. Morton

Surgical Service, Veterans Administration Medical Center, Sepulveda, California 91343 [N. T., D. H. K., D. L. M.]; Division of Surgical Oncology, John Wayne Clinic, UCLA School of Medicine, Los Angeles, California 90024 [N. T., D. H. K., D. L. M.], and Department of Surgery, University of Kyoto, Sakyo-ku, Kyoto, Japan [Y. H.]

Assays that measure [3H]thymidine incorporation by cells plated in soft agar were investigated to identify a rapid method for assessing chemosensitivity of tumor cells. Six established cell lines (five melanomas and one colon carcinoma) and cells prepared from 23 primary or metastatic tumors (ten melanomas, five colon adenocarcinomas, three lung carcinomas, two ovarian adenocarcinomas, one breast adenocarcinoma, and one leiomyosarcoma) were tested. The end point of tritium incorporation was measured by autoradiographs (labeling index) and scintillation counting (cpm) after 24-hr labeling. When results were compared, there was a strong correlation between the two assays (p < 0.0001).

However, the scintillation counting assay had major advantages: (a) counting incorporated radioisotope was technically easier than the autoradiographic method; (b) the DNA synthesis rate of the whole tumor cell population could be evaluated, not that of tumor colony-forming cells alone; and (c) the sampling error was minimized since the procedure was done automatically. There was significant association between cpm values 48 to 72 hr after plating and the number of colonies formed at 2 to 4 weeks in control dishes (p < 0.001). Eighteen of 23 surgical specimens (78%) and all four cell lines were evaluable. Chemosensitivity was assessed after 48 hr of plating with alkylating agents, antibiotics, and Vinca alkaloids and after 72 hr with 5-fluorouracil and methotrexate. Results of 93 courses of drug-related inhibition of colony formation were compared to results of the scintillation assay. Results suggested that an 80% or greater reduction of [3H]thymidine incorporation was correlated with a 75% or greater decrease in colony growth (p < 0.0001). Thus, this scintillation assay accurately predicted drug-tumor interactions within 5 days that resulted in a 75% or greater decrease in colonies.

1 Supported by Veterans Administration Medical Research Service.

2 Present address: Department of Surgery, University of Kyoto, Sakyo-ku, Kyoto, Japan. To whom requests for reprints should be addressed, at the Division of Surgical Oncology, Ninth Floor, Factor Building, UCLA School of Medicine, Los Angeles, Calif. 90024.

Received 7/ 6/81. Accepted 3/ 2/82.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Maruno, A. Absood, and S. I. Said
Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo
PNAS, November 24, 1998; 95(24): 14373 - 14378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lavie, H.-t. Cao, A. Volner, A. Lucci, T.-Y. Han, V. Geffen, A. E. Giuliano, and M. C. Cabot
Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells
J. Biol. Chem., January 17, 1997; 272(3): 1682 - 1687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.